 | 8PT | Name: | ~{N}6-cyclohexyl-~{N}2-(2-methyl-4-morpholin-4-yl-phenyl)-7~{H}-purine-2,6-diamine | Formula: | C22 H29 N7 O | SMILES: | Cc1cc(ccc1Nc2nc(NC3CCCCC3)c4[nH]cnc4n2)N5CCOCC5 | InChi: | InChI=1S/C22H29N7O/c1-15-13-17(29-9-11-30-12-10-29)7-8-18(15)26-22-27-20-19(23-14-24-20)21(28-22)25-16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H3,23,24,25,26,27,28) | Definition date: | 2017-02-21 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}6-cyclohexyl-~{N}2-(2-methyl-4-morpholin-4-yl-phenyl)-7~{H}-purine-2,6-diamine |
|
 | 8Q5 | Name: | ~{N}-cyclopropyl-4-[8-(2-methylpropylamino)imidazo[1,2-a]pyrazin-3-yl]benzamide | Formula: | C20 H23 N5 O | SMILES: | CC(C)CNc1nccn2c(cnc12)c3ccc(cc3)C(=O)NC4CC4 | InChi: | InChI=1S/C20H23N5O/c1-13(2)11-22-18-19-23-12-17(25(19)10-9-21-18)14-3-5-15(6-4-14)20(26)24-16-7-8-16/h3-6,9-10,12-13,16H,7-8,11H2,1-2H3,(H,21,22)(H,24,26) | Definition date: | 2017-02-23 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}-cyclopropyl-4-[8-(2-methylpropylamino)imidazo[1,2-a]pyrazin-3-yl]benzamide |
|
 | 8QE | Name: | 4-[[4-azanyl-6-(~{tert}-butylamino)-5-cyano-pyridin-2-yl]amino]benzamide | Formula: | C17 H20 N6 O | SMILES: | CC(C)(C)Nc1nc(Nc2ccc(cc2)C(N)=O)cc(N)c1C#N | InChi: | InChI=1S/C17H20N6O/c1-17(2,3)23-16-12(9-18)13(19)8-14(22-16)21-11-6-4-10(5-7-11)15(20)24/h4-8H,1-3H3,(H2,20,24)(H4,19,21,22,23) | Definition date: | 2017-02-24 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-[[4-azanyl-6-(~{tert}-butylamino)-5-cyano-pyridin-2-yl]amino]benzamide |
|
 | 8QW | Name: | (2~{R})-2-(4-fluorophenyl)-~{N}-[4-[2-[(2-methoxy-4-methylsulfonyl-phenyl)amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide | Formula: | C29 H26 F N5 O4 S | SMILES: | COc1cc(ccc1Nc2nn3cc(ccc3n2)c4ccc(NC(=O)[CH](C)c5ccc(F)cc5)cc4)[S](C)(=O)=O | InChi: | InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1 | Definition date: | 2017-02-27 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | (2~{R})-2-(4-fluorophenyl)-~{N}-[4-[2-[(2-methoxy-4-methylsulfonyl-phenyl)amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide |
|
 | 8QZ | Name: | ~{N}-[3,5-diethyl-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]pyrazol-4-yl]-2-[[2-methoxy-4-[4-(2-methoxyethanoyl)piperazin-1-yl]phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide | Formula: | C39 H53 N9 O7 | SMILES: | CCc1nn(CCOCCOCCOC)c(CC)c1NC(=O)c2ccn3c2CCc4cnc(Nc5ccc(cc5OC)N6CCN(CC6)C(=O)COC)nc34 | InChi: | InChI=1S/C39H53N9O7/c1-6-30-36(32(7-2)48(44-30)18-19-54-22-23-55-21-20-51-3)42-38(50)29-12-13-47-33(29)11-8-27-25-40-39(43-37(27)47)41-31-10-9-28(24-34(31)53-5)45-14-16-46(17-15-45)35(49)26-52-4/h9-10,12-13,24-25H,6-8,11,14-23,26H2,1-5H3,(H,42,50)(H,40,41,43) | Definition date: | 2017-02-27 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | ~{N}-[3,5-diethyl-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]pyrazol-4-yl]-2-[[2-methoxy-4-[4-(2-methoxyethanoyl)piperazin-1-yl]phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide |
|
 | 8RH | Name: | BAY 1217389 | Formula: | C27 H24 F5 N5 O3 | SMILES: | COc1ccc(Oc2cc(NCCC(F)(F)F)c3ncc(n3n2)c4ccc(c(C)c4)C(=O)NC5CC5)c(F)c1F | InChi: | InChI=1S/C27H24F5N5O3/c1-14-11-15(3-6-17(14)26(38)35-16-4-5-16)19-13-34-25-18(33-10-9-27(30,31)32)12-22(36-37(19)25)40-21-8-7-20(39-2)23(28)24(21)29/h3,6-8,11-13,16,33H,4-5,9-10H2,1-2H3,(H,35,38) | Definition date: | 2017-02-28 | Last modified: | 2017-05-26 | Release date: | 2017-05-31 | Identifier: | 4-[6-[2,3-bis(fluoranyl)-4-methoxy-phenoxy]-8-[3,3,3-tris(fluoranyl)propylamino]imidazo[1,2-b]pyridazin-3-yl]-~{N}-cyclopropyl-2-methyl-benzamide |
|
 | YRA | Name: | 3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propanamide | Formula: | C16 H17 Cl N2 O | SMILES: | NC(=O)CCNCc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C16H17ClN2O/c17-15-10-12(11-19-9-8-16(18)20)6-7-14(15)13-4-2-1-3-5-13/h1-7,10,19H,8-9,11H2,(H2,18,20) | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propanamide |
|
 | JMB | Name: | (3-chloranyl-4-phenyl-phenyl)methyl-propyl-azanium | Formula: | C16 H19 Cl N | SMILES: | CCC[NH2+]Cc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C16H18ClN/c1-2-10-18-12-13-8-9-15(16(17)11-13)14-6-4-3-5-7-14/h3-9,11,18H,2,10,12H2,1H3/p+1 | Definition date: | 2016-12-08 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | (3-chloranyl-4-phenyl-phenyl)methyl-propyl-azanium |
|
 | J2P | Name: | (3-chloranyl-4-phenyl-phenyl)methyl-ethyl-azanium | Formula: | C15 H17 Cl N | SMILES: | CC[NH2+]Cc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C15H16ClN/c1-2-17-11-12-8-9-14(15(16)10-12)13-6-4-3-5-7-13/h3-10,17H,2,11H2,1H3/p+1 | Definition date: | 2016-12-16 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | (3-chloranyl-4-phenyl-phenyl)methyl-ethyl-azanium |
|
 | C8L | Name: | Cucurbit[8]uril | Formula: | C48 H48 N32 O16 | SMILES: | O=C1[N]2C[N]3C4C5[N](C[N]6C7C8[N](C[N]9C%10C%11[N](C[N]%12C%13C%14[N](C[N]%15C%16C%17[N](C[N]%18C%19C%20[N](C[N]%21C%22C%23[N](C[N]1C%24C2N%25CN4C(=O)N5CN7C(=O)N8CN%10C(=O)N%11CN%13C(=O)N%14CN%16C(=O)N%17CN%19C(=O)N%20CN%22C(=O)N%23CN%24C%25=O)C%21=O)C%18=O)C%15=O)C%12=O)C9=O)C6=O)C3=O | InChi: | InChI=1S/C48H48N32O16/c81-33-49-1-50-18-20-54(34(50)82)4-58-22-24-62(38(58)86)8-66-26-28-70(42(66)90)12-74-30-32-78(46(74)94)15-77-31-29-73(45(77)93)11-69-27-25-65(41(69)89)7-61-23-21-57(37(61)85)3-53(33)19-17(49)51-2-52(18)36(84)56(20)6-60(22)40(88)64(24)10-68(26)44(92)72(28)14-76(30)48(96)80(32)16-79(31)47(95)75(29)13-71(27)43(91)67(25)9-63(23)39(87)59(21)5-55(19)35(51)83/h17-32H,1-16H2/t17-,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,28-,29-,30+,31+,32- | Definition date: | 2017-02-05 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 |
|
 | C98 | Name: | 3-[[3-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propylamino]-3-oxidanylidene-propanoyl]amino]benzoic acid | Formula: | C26 H26 Cl N3 O4 | SMILES: | OC(=O)c1cccc(NC(=O)CC(=O)NCCCNCc2ccc(c(Cl)c2)c3ccccc3)c1 | InChi: | InChI=1S/C26H26ClN3O4/c27-23-14-18(10-11-22(23)19-6-2-1-3-7-19)17-28-12-5-13-29-24(31)16-25(32)30-21-9-4-8-20(15-21)26(33)34/h1-4,6-11,14-15,28H,5,12-13,16-17H2,(H,29,31)(H,30,32)(H,33,34) | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 3-[[3-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propylamino]-3-oxidanylidene-propanoyl]amino]benzoic acid |
|
 | KXZ | Name: | 3-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propylamino]-3-oxidanylidene-propanoic acid | Formula: | C19 H21 Cl N2 O3 | SMILES: | OC(=O)CC(=O)NCCCNCc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C19H21ClN2O3/c20-17-11-14(7-8-16(17)15-5-2-1-3-6-15)13-21-9-4-10-22-18(23)12-19(24)25/h1-3,5-8,11,21H,4,9-10,12-13H2,(H,22,23)(H,24,25) | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 3-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propylamino]-3-oxidanylidene-propanoic acid |
|
 | H83 | Name: | ~{N}'-[(3-chloranyl-4-phenyl-phenyl)methyl]butane-1,4-diamine | Formula: | C17 H21 Cl N2 | SMILES: | NCCCCNCc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C17H21ClN2/c18-17-12-14(13-20-11-5-4-10-19)8-9-16(17)15-6-2-1-3-7-15/h1-3,6-9,12,20H,4-5,10-11,13,19H2 | Definition date: | 2016-12-12 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | ~{N}'-[(3-chloranyl-4-phenyl-phenyl)methyl]butane-1,4-diamine |
|
 | 4IH | Name: | ~{N}-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propyl]methanesulfonamide | Formula: | C17 H21 Cl N2 O2 S | SMILES: | C[S](=O)(=O)NCCCNCc1ccc(c(Cl)c1)c2ccccc2 | InChi: | InChI=1S/C17H21ClN2O2S/c1-23(21,22)20-11-5-10-19-13-14-8-9-16(17(18)12-14)15-6-3-2-4-7-15/h2-4,6-9,12,19-20H,5,10-11,13H2,1H3 | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | ~{N}-[3-[(3-chloranyl-4-phenyl-phenyl)methylamino]propyl]methanesulfonamide |
|
 | 74G | Name: | 4-{[(2S)-3-{2,16-dioxo-20-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2,3-dihydro-1,3-benzothiazol-2-yl]methyl}-1-methylquinolin-1-ium | Formula: | C38 H51 N6 O6 S2 | SMILES: | C12NC(NC1C(SC2)CCCCC(NCCOCCOCCOCCNC(=O)CN3C(Sc4c3cccc4)Cc5cc[n+](C)c6c5cccc6)=O)=O | InChi: | InChI=1S/C38H50N6O6S2/c1-43-17-14-27(28-8-2-3-9-30(28)43)24-36-44(31-10-4-5-11-32(31)52-36)25-35(46)40-16-19-49-21-23-50-22-20-48-18-15-39-34(45)13-7-6-12-33-37-29(26-51-33)41-38(47)42-37/h2-5,8-11,14,17,29,33,36-37H,6-7,12-13,15-16,18-26H2,1H3,(H3-,39,40,41,42,45,46,47)/p+1/t29-,33-,36-,37-/m0/s1 | Definition date: | 2016-08-23 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 4-{[(2S)-3-{2,16-dioxo-20-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2,3-dihydro-1,3-benzothiazol-2-yl]methyl}-1-methylquinolin-1-ium |
|
 | 6K8 | Name: | N-(benzenecarbonyl)glycyl-L-arginine | Formula: | C15 H21 N5 O4 | SMILES: | N/C(NCCCC(NC(=O)CNC(c1ccccc1)=O)C(O)=O)=N | InChi: | InChI=1S/C15H21N5O4/c16-15(17)18-8-4-7-11(14(23)24)20-12(21)9-19-13(22)10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,19,22)(H,20,21)(H,23,24)(H4,16,17,18)/t11-/m0/s1 | Definition date: | 2016-04-21 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | N-(benzenecarbonyl)glycyl-L-arginine |
|
 | 6MM | Name: | 6-amino-2-({[(3a'R,4S,6'R,6a'R)-2,2,2',2'-tetramethyldihydro-3a'H-spiro[1,3-dioxolane-4,4'-furo[3,4-d][1,3]dioxol]-6'-yl]methyl}amino)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one (non-preferred name) | Formula: | C21 H26 N6 O6 | SMILES: | C6(OCC4(OC(CNc3nc2cc1C(=O)NC(N)=Nc1cc2n3)C5OC(OC45)(C)C)O6)(C)C | InChi: | InChI=1S/C21H26N6O6/c1-19(2)29-8-21(33-19)15-14(31-20(3,4)32-15)13(30-21)7-23-18-25-11-5-9-10(6-12(11)26-18)24-17(22)27-16(9)28/h5-6,13-15H,7-8H2,1-4H3,(H2,23,25,26)(H3,22,24,27,28)/t13-,14-,15-,21+/m1/s1 | Definition date: | 2016-05-09 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 6-amino-2-({[(3a'R,4S,6'R,6a'R)-2,2,2',2'-tetramethyldihydro-3a'H-spiro[1,3-dioxolane-4,4'-furo[3,4-d][1,3]dioxol]-6'-yl]methyl}amino)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one (non-preferred name) |
|
 | 6MQ | Name: | methyl 5-[(6-amino-8-oxo-7,8-dihydro-3H-imidazo[4,5-g]quinazolin-2-yl)amino]-5-deoxy-2,3-O-(1-methylethylidene)-beta-D-ribofuranoside | Formula: | C18 H22 N6 O5 | SMILES: | COC4C5C(C(CNc3nc1c(cc2c(c1)N=C(NC2=O)N)n3)O4)OC(O5)(C)C | InChi: | InChI=1S/C18H22N6O5/c1-18(2)28-12-11(27-15(26-3)13(12)29-18)6-20-17-22-9-4-7-8(5-10(9)23-17)21-16(19)24-14(7)25/h4-5,11-13,15H,6H2,1-3H3,(H2,20,22,23)(H3,19,21,24,25)/t11-,12-,13-,15-/m1/s1 | Definition date: | 2016-05-09 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | methyl 5-[(6-amino-8-oxo-7,8-dihydro-3H-imidazo[4,5-g]quinazolin-2-yl)amino]-5-deoxy-2,3-O-(1-methylethylidene)-beta-D-ribofuranoside |
|
 | 6N1 | Name: | 2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazole-6-carbohydrazide | Formula: | C14 H20 N6 O2 | SMILES: | c3(C(=O)NN)ccc1c(nc(n1)NCCN2CCOCC2)c3 | InChi: | InChI=1S/C14H20N6O2/c15-19-13(21)10-1-2-11-12(9-10)18-14(17-11)16-3-4-20-5-7-22-8-6-20/h1-2,9H,3-8,15H2,(H,19,21)(H2,16,17,18) | Definition date: | 2016-05-10 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazole-6-carbohydrazide |
|
 | 6N2 | Name: | N-(2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazol-5-yl)guanidine | Formula: | C14 H21 N7 O | SMILES: | NC(=N)Nc3ccc2nc(NCCN1CCOCC1)nc2c3 | InChi: | InChI=1S/C14H21N7O/c15-13(16)18-10-1-2-11-12(9-10)20-14(19-11)17-3-4-21-5-7-22-8-6-21/h1-2,9H,3-8H2,(H4,15,16,18)(H2,17,19,20) | Definition date: | 2016-05-10 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | N-(2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazol-5-yl)guanidine |
|
 | 6NK | Name: | 2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazole-6-carboxamide | Formula: | C14 H19 N5 O2 | SMILES: | c3(C(=O)N)ccc1c(nc(n1)NCCN2CCOCC2)c3 | InChi: | InChI=1S/C14H19N5O2/c15-13(20)10-1-2-11-12(9-10)18-14(17-11)16-3-4-19-5-7-21-8-6-19/h1-2,9H,3-8H2,(H2,15,20)(H2,16,17,18) | Definition date: | 2016-05-11 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 2-{[2-(morpholin-4-yl)ethyl]amino}-1H-benzimidazole-6-carboxamide |
|
 | 6PD | Name: | [4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]-[4-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]carbonyl-3-[[4-(pyrrolidin-1-ylmethoxy)phenyl]amino]phenyl]methanone | Formula: | C41 H60 N6 O3 | SMILES: | O=C(N1CC[CH](CCN2CCCC2)CC1)c3ccc(C(=O)N4CC[CH](CCN5CCCC5)CC4)c(Nc6ccc(OCN7CCCC7)cc6)c3 | InChi: | InChI=1S/C41H60N6O3/c48-40(46-27-15-33(16-28-46)13-25-43-19-1-2-20-43)35-7-12-38(41(49)47-29-17-34(18-30-47)14-26-44-21-3-4-22-44)39(31-35)42-36-8-10-37(11-9-36)50-32-45-23-5-6-24-45/h7-12,31,33-34,42H,1-6,13-30,32H2 | Definition date: | 2016-05-18 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | [4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]-[4-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]carbonyl-3-[[4-(pyrrolidin-1-ylmethoxy)phenyl]amino]phenyl]methanone |
|
 | OQC | Name: | [3-chloranyl-4-(furan-3-yl)phenyl]methanamine | Formula: | C11 H10 Cl N O | SMILES: | NCc1ccc(c(Cl)c1)c2cocc2 | InChi: | InChI=1S/C11H10ClNO/c12-11-5-8(6-13)1-2-10(11)9-3-4-14-7-9/h1-5,7H,6,13H2 | Definition date: | 2016-12-14 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | [3-chloranyl-4-(furan-3-yl)phenyl]methanamine |
|
 | 7G6 | Name: | 6-cyclopropyl-8-fluoranyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]-6-oxidanylidene-pyridin-3-yl]phenyl]isoquinolin-1-one | Formula: | C35 H35 F N6 O3 | SMILES: | CN1CCN(CC1)c2ccc(NC3=CC(=CN(C)C3=O)c4cccc(N5C=Cc6cc(cc(F)c6C5=O)C7CC7)c4CO)nc2 | InChi: | InChI=1S/C35H35FN6O3/c1-39-12-14-41(15-13-39)26-8-9-32(37-19-26)38-30-18-25(20-40(2)34(30)44)27-4-3-5-31(28(27)21-43)42-11-10-23-16-24(22-6-7-22)17-29(36)33(23)35(42)45/h3-5,8-11,16-20,22,43H,6-7,12-15,21H2,1-2H3,(H,37,38) | Definition date: | 2016-10-19 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 6-cyclopropyl-8-fluoranyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]-6-oxidanylidene-pyridin-3-yl]phenyl]isoquinolin-1-one |
|
 | 7G7 | Name: | 6-~{tert}-butyl-8-fluoranyl-2-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-(1-methylpiperidin-4-yl)pyridin-2-yl]amino]-6-oxidanylidene-pyridazin-3-yl]pyridin-2-yl]phthalazin-1-one | Formula: | C34 H37 F N8 O3 | SMILES: | CN1CCC(CC1)c2ccc(NC3=CC(=NN(C)C3=O)c4ccnc(N5N=Cc6cc(cc(F)c6C5=O)C(C)(C)C)c4CO)nc2 | InChi: | InChI=1S/C34H37FN8O3/c1-34(2,3)23-14-22-18-38-43(33(46)30(22)26(35)15-23)31-25(19-44)24(8-11-36-31)27-16-28(32(45)42(5)40-27)39-29-7-6-21(17-37-29)20-9-12-41(4)13-10-20/h6-8,11,14-18,20,44H,9-10,12-13,19H2,1-5H3,(H,37,39) | Definition date: | 2016-10-19 | Last modified: | 2017-05-19 | Release date: | 2017-05-24 | Identifier: | 6-~{tert}-butyl-8-fluoranyl-2-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-(1-methylpiperidin-4-yl)pyridin-2-yl]amino]-6-oxidanylidene-pyridazin-3-yl]pyridin-2-yl]phthalazin-1-one |
|